Pr3vent

Pr3vent, Inc. (pronounced "pr-vent") is a Palo Alto, Calif.-based healthcare technology company co-founded in 2017 by noted medical field veterans Jochen Kumm, PhD and Darius M. Moshfeghi, MD. Their combined expertise in deep learning, ophthalmic markets and telemedicine for retinal disease helped develop an AI platform for early detection of preventable vision loss in newborns. The company's first product will be an autonomous scalable AI system for detecting abnormality in newborn retinas.